Selected Cell
Cell:
Value:
Pcitri.ignored_ids.dumb.final.p
Sheet3
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
17401
17402
17403
17404
17405
17406
17407
17408
17409
17410
17411
17412
17413
17414
17415
17416
17417
17418
17419
17420
17421
17422
17423
17424
17425
17426
17427
17428
17429
17430
17431
17432
17433
17434
17435
17436
17437
17438
17439
17440
17441
17442
17443
17444
17445
17446
17447
17448
17449
17450
17451
17452
17453
17454
17455
17456
17457
17458
17459
17460
17461
17462
17463
17464
17465
17466
17467
17468
17469
17470
17471
17472
17473
17474
17475
17476
17477
17478
17479
17480
17481
17482
17483
17484
17485
17486
17487
17488
17489
17490
17491
17492
17493
17494
17495
17496
17497
17498
17499
17500
17501
17502
17503
17504
17505
17506
17507
17508
17509
17510
17511
17512
17513
17514
17515
17516
17517
17518
17519
17520
17521
17522
17523
17524
17525
17526
17527
17528
17529
17530
17531
17532
17533
17534
17535
17536
17537
17538
17539
17540
17541
17542
17543
17544
17545
17546
17547
17548
17549
17550
17551
17552
17553
17554
17555
17556
17557
17558
17559
17560
17561
17562
17563
17564
17565
17566
17567
17568
17569
17570
17571
17572
17573
17574
17575
17576
17577
17578
17579
17580
17581
17582
17583
17584
17585
17586
17587
17588
17589
17590
17591
17592
17593
17594
17595
17596
17597
17598
17599
17600
| UnnamedSample_HQ_transcript/35103|m.10735 | UnnamedSample_HQ_transcript/35103 | Coverage 0.496 too low. | c39ab103896b497474a78c98f9a0ad24 | 730 | Pfam | PF12066 | SERRATE/Ars2, N-terminal domain | 59 | 168 | 3.2E-36 | T | 22-09-2020 | IPR021933 | SERRATE/Ars2, N-terminal |
| UnnamedSample_HQ_transcript/35103|m.10735 | UnnamedSample_HQ_transcript/35103 | Coverage 0.496 too low. | c39ab103896b497474a78c98f9a0ad24 | 730 | Pfam | PF04959 | Arsenite-resistance protein 2 | 519 | 713 | 5.7E-54 | T | 22-09-2020 | IPR007042 | SERRATE/Ars2 , C-terminal |
| UnnamedSample_HQ_transcript/45448|m.13016 | UnnamedSample_HQ_transcript/45448 | Coverage 0.728 too low. | 4a1b0a841c9ec6bfe10c7aa9307c8e41 | 269 | Pfam | PF00001 | 7 transmembrane receptor (rhodopsin family) | 2 | 226 | 1.1E-41 | T | 22-09-2020 | IPR017452 | GPCR, rhodopsin-like, 7TM |
| UnnamedSample_HQ_transcript/67779|m.17540 | UnnamedSample_HQ_transcript/67779 | Coverage 0.810 too low. | 4a1b0a841c9ec6bfe10c7aa9307c8e41 | 269 | Pfam | PF00001 | 7 transmembrane receptor (rhodopsin family) | 2 | 226 | 1.1E-41 | T | 22-09-2020 | IPR017452 | GPCR, rhodopsin-like, 7TM |
| UnnamedSample_HQ_transcript/28368|m.9061 | UnnamedSample_HQ_transcript/28368 | Coverage 0.425 too low. | 2b473419dcf5ee7e9c3591acac75da45 | 476 | Pfam | PF07690 | Major Facilitator Superfamily | 9 | 397 | 9.7E-40 | T | 22-09-2020 | IPR011701 | Major facilitator superfamily |
| UnnamedSample_HQ_transcript/4347|m.1935 | UnnamedSample_HQ_transcript/4347 | Identity 0.932 too low. | 74e914ce2f3a79f8ee778a7aaff9f187 | 1493 | Pfam | PF00439 | Bromodomain | 1279 | 1361 | 4.3E-18 | T | 22-09-2020 | IPR001487 | Bromodomain |
| UnnamedSample_HQ_transcript/4347|m.1935 | UnnamedSample_HQ_transcript/4347 | Identity 0.932 too low. | 74e914ce2f3a79f8ee778a7aaff9f187 | 1493 | Pfam | PF02135 | TAZ zinc finger | 371 | 448 | 4.9E-20 | T | 22-09-2020 | IPR000197 | Zinc finger, TAZ-type |
| UnnamedSample_HQ_transcript/4347|m.1935 | UnnamedSample_HQ_transcript/4347 | Identity 0.932 too low. | 74e914ce2f3a79f8ee778a7aaff9f187 | 1493 | Pfam | PF06001 | Domain of Unknown Function (DUF902) | 1373 | 1412 | 3.2E-23 | T | 22-09-2020 | IPR010303 | CREB-binding protein/p300, atypical RING domain |
| UnnamedSample_HQ_transcript/4347|m.1935 | UnnamedSample_HQ_transcript/4347 | Identity 0.932 too low. | 74e914ce2f3a79f8ee778a7aaff9f187 | 1493 | Pfam | PF02172 | KIX domain | 727 | 756 | 9.7E-6 | T | 22-09-2020 | IPR003101 | Coactivator CBP, KIX domain |
| UnnamedSample_HQ_transcript/4347|m.1935 | UnnamedSample_HQ_transcript/4347 | Identity 0.932 too low. | 74e914ce2f3a79f8ee778a7aaff9f187 | 1493 | Pfam | PF02172 | KIX domain | 792 | 837 | 2.0E-13 | T | 22-09-2020 | IPR003101 | Coactivator CBP, KIX domain |
| UnnamedSample_HQ_transcript/6155|m.2592 | UnnamedSample_HQ_transcript/6155 | Identity 0.927 too low. | 74e914ce2f3a79f8ee778a7aaff9f187 | 1493 | Pfam | PF00439 | Bromodomain | 1279 | 1361 | 4.3E-18 | T | 22-09-2020 | IPR001487 | Bromodomain |
| UnnamedSample_HQ_transcript/6155|m.2592 | UnnamedSample_HQ_transcript/6155 | Identity 0.927 too low. | 74e914ce2f3a79f8ee778a7aaff9f187 | 1493 | Pfam | PF02135 | TAZ zinc finger | 371 | 448 | 4.9E-20 | T | 22-09-2020 | IPR000197 | Zinc finger, TAZ-type |
| UnnamedSample_HQ_transcript/6155|m.2592 | UnnamedSample_HQ_transcript/6155 | Identity 0.927 too low. | 74e914ce2f3a79f8ee778a7aaff9f187 | 1493 | Pfam | PF06001 | Domain of Unknown Function (DUF902) | 1373 | 1412 | 3.2E-23 | T | 22-09-2020 | IPR010303 | CREB-binding protein/p300, atypical RING domain |
| UnnamedSample_HQ_transcript/6155|m.2592 | UnnamedSample_HQ_transcript/6155 | Identity 0.927 too low. | 74e914ce2f3a79f8ee778a7aaff9f187 | 1493 | Pfam | PF02172 | KIX domain | 727 | 756 | 9.7E-6 | T | 22-09-2020 | IPR003101 | Coactivator CBP, KIX domain |
| UnnamedSample_HQ_transcript/6155|m.2592 | UnnamedSample_HQ_transcript/6155 | Identity 0.927 too low. | 74e914ce2f3a79f8ee778a7aaff9f187 | 1493 | Pfam | PF02172 | KIX domain | 792 | 837 | 2.0E-13 | T | 22-09-2020 | IPR003101 | Coactivator CBP, KIX domain |
| UnnamedSample_HQ_transcript/55129|m.15062 | UnnamedSample_HQ_transcript/55129 | Coverage 0.414 too low. | 8ec5dcb982c169ca543ba5a30ddcb402 | 351 | Pfam | PF00982 | Glycosyltransferase family 20 | 16 | 340 | 5.2E-79 | T | 22-09-2020 | IPR001830 | Glycosyl transferase, family 20 |
| UnnamedSample_HQ_transcript/69580|m.17855 | UnnamedSample_HQ_transcript/69580 | Coverage 0.798 too low. | f3a9752c0a847773ddce091951da3958 | 448 | Pfam | PF13401 | AAA domain | 104 | 226 | 6.9E-13 | T | 22-09-2020 | IPR003593 | AAA+ ATPase domain |
| UnnamedSample_HQ_transcript/69580|m.17855 | UnnamedSample_HQ_transcript/69580 | Coverage 0.798 too low. | f3a9752c0a847773ddce091951da3958 | 448 | Pfam | PF09079 | CDC6, C terminal winged helix domain | 355 | 433 | 3.1E-10 | T | 22-09-2020 | IPR015163 | Cdc6, C-terminal |
| UnnamedSample_HQ_transcript/94804|m.21925 | UnnamedSample_HQ_transcript/94804 | Identity 0.798 too low. | 3baf9207719f0fb93f50fc0619d7cdd7 | 152 | Pfam | PF13640 | 2OG-Fe(II) oxygenase superfamily | 24 | 117 | 5.3E-22 | T | 22-09-2020 | IPR005123 | Oxoglutarate/iron-dependent dioxygenase |
| UnnamedSample_HQ_transcript/100943|m.22748 | UnnamedSample_HQ_transcript/100943 | Identity 0.902 too low. | 3baf9207719f0fb93f50fc0619d7cdd7 | 152 | Pfam | PF13640 | 2OG-Fe(II) oxygenase superfamily | 24 | 117 | 5.3E-22 | T | 22-09-2020 | IPR005123 | Oxoglutarate/iron-dependent dioxygenase |
| UnnamedSample_HQ_transcript/57176|m.15484 | UnnamedSample_HQ_transcript/57176 | Identity 0.934 too low. | 862739efaca97a1eee56cc0623402100 | 579 | Pfam | PF01204 | Trehalase | 32 | 544 | 4.1E-150 | T | 22-09-2020 | IPR001661 | Glycoside hydrolase, family 37 |
| UnnamedSample_HQ_transcript/6170|m.2598 | UnnamedSample_HQ_transcript/6170 | Coverage 0.799 too low. | e24c33ff4d95a393847315cb160bafe2 | 628 | Pfam | PF13894 | C2H2-type zinc finger | 259 | 280 | 2.9E-4 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/6170|m.2598 | UnnamedSample_HQ_transcript/6170 | Coverage 0.799 too low. | e24c33ff4d95a393847315cb160bafe2 | 628 | Pfam | PF00096 | Zinc finger, C2H2 type | 289 | 311 | 3.4E-4 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/6170|m.2598 | UnnamedSample_HQ_transcript/6170 | Coverage 0.799 too low. | e24c33ff4d95a393847315cb160bafe2 | 628 | Pfam | PF00096 | Zinc finger, C2H2 type | 317 | 337 | 0.0033 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/84943|m.20492 | UnnamedSample_HQ_transcript/84943 | Coverage 0.442 too low. | 0564148d15b3e9fdf039fc030dc5f36d | 163 | Pfam | PF02181 | Formin Homology 2 Domain | 34 | 144 | 2.6E-12 | T | 22-09-2020 | IPR015425 | Formin, FH2 domain |
| UnnamedSample_HQ_transcript/112991|m.24184 | UnnamedSample_HQ_transcript/112991 | Identity 0.436 too low. | 65f9aa934f3c8f33bf638593b40c3a64 | 184 | Pfam | PF07648 | Kazal-type serine protease inhibitor domain | 113 | 159 | 0.047 | T | 22-09-2020 | IPR002350 | Kazal domain |
| UnnamedSample_HQ_transcript/112991|m.24184 | UnnamedSample_HQ_transcript/112991 | Identity 0.436 too low. | 65f9aa934f3c8f33bf638593b40c3a64 | 184 | Pfam | PF00050 | Kazal-type serine protease inhibitor domain | 40 | 82 | 8.9E-5 | T | 22-09-2020 | IPR002350 | Kazal domain |
| UnnamedSample_HQ_transcript/12584|m.4689 | UnnamedSample_HQ_transcript/12584 | Identity 0.762 too low. | b64b6f001a3687e18e9331ed5d7ce59e | 1155 | Pfam | PF18701 | Family of unknown function (DUF5641) | 1053 | 1146 | 1.9E-33 | T | 22-09-2020 | IPR040676 | Domain of unknown function DUF5641 |
| UnnamedSample_HQ_transcript/12584|m.4689 | UnnamedSample_HQ_transcript/12584 | Identity 0.762 too low. | b64b6f001a3687e18e9331ed5d7ce59e | 1155 | Pfam | PF05380 | Pao retrotransposon peptidase | 374 | 539 | 4.0E-49 | T | 22-09-2020 | IPR008042 | Retrotransposon, Pao |
| UnnamedSample_HQ_transcript/123|m.122 | UnnamedSample_HQ_transcript/123 | Coverage 0.892 too low. | a82f920b5b85de2929b1b4242d034246 | 2204 | Pfam | PF18296 | MID domain of medPIWI | 1449 | 1725 | 6.7E-71 | T | 22-09-2020 | IPR041285 | MID domain of medPIWI |
| UnnamedSample_HQ_transcript/123|m.122 | UnnamedSample_HQ_transcript/123 | Coverage 0.892 too low. | a82f920b5b85de2929b1b4242d034246 | 2204 | Pfam | PF06333 | Mediator complex subunit 13 C-terminal domain | 1763 | 2193 | 2.0E-110 | T | 22-09-2020 | IPR009401 | Mediator complex subunit Med13, C-terminal |
| UnnamedSample_HQ_transcript/54547|m.14956 | UnnamedSample_HQ_transcript/54547 | Coverage 0.887 too low. | e0ff44673d773745875720bcc3abd3f5 | 482 | Pfam | PF14786 | Tube Death domain | 6 | 126 | 1.2E-23 | T | 22-09-2020 | IPR029397 | Tube, Death domain |
| UnnamedSample_HQ_transcript/54547|m.14956 | UnnamedSample_HQ_transcript/54547 | Coverage 0.887 too low. | e0ff44673d773745875720bcc3abd3f5 | 482 | Pfam | PF00069 | Protein kinase domain | 203 | 465 | 1.5E-43 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/73827|m.18617 | UnnamedSample_HQ_transcript/73827 | Coverage 0.974 too low. | e0ff44673d773745875720bcc3abd3f5 | 482 | Pfam | PF14786 | Tube Death domain | 6 | 126 | 1.2E-23 | T | 22-09-2020 | IPR029397 | Tube, Death domain |
| UnnamedSample_HQ_transcript/73827|m.18617 | UnnamedSample_HQ_transcript/73827 | Coverage 0.974 too low. | e0ff44673d773745875720bcc3abd3f5 | 482 | Pfam | PF00069 | Protein kinase domain | 203 | 465 | 1.5E-43 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/58372|m.15728 | UnnamedSample_HQ_transcript/58372 | Coverage 0.512 too low. | f5a9c955902c5d18dbd67cad2a1de7c9 | 314 | Pfam | PF05485 | THAP domain | 70 | 140 | 2.2E-10 | T | 22-09-2020 | IPR006612 | THAP-type zinc finger |
| UnnamedSample_HQ_transcript/20091|m.6900 | UnnamedSample_HQ_transcript/20091 | Coverage 0.123 too low. | 97d7f5796b4a464192c83a018e4d0579 | 403 | Pfam | PF12448 | Kinesin associated protein | 57 | 201 | 7.7E-21 | T | 22-09-2020 | IPR022154 | Trafficking kinesin-binding protein, C-terminal |
| UnnamedSample_HQ_transcript/37861|m.11362 | UnnamedSample_HQ_transcript/37861 | Coverage 0.062 too low. | bb5540649e4a828818ec0093e0beda15 | 180 | Pfam | PF13896 | Glycosyl-transferase for dystroglycan | 10 | 173 | 1.6E-49 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/13484|m.4947 | UnnamedSample_HQ_transcript/13484 | Coverage 0.147 too low. | bb5540649e4a828818ec0093e0beda15 | 180 | Pfam | PF13896 | Glycosyl-transferase for dystroglycan | 10 | 173 | 1.6E-49 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/4812|m.2122 | UnnamedSample_HQ_transcript/4812 | Coverage 0.929 too low. | 1b6e9ef15c403673a913a7674fbc0cd4 | 322 | Pfam | PF07714 | Protein tyrosine and serine/threonine kinase | 2 | 225 | 7.1E-78 | T | 22-09-2020 | IPR001245 | Serine-threonine/tyrosine-protein kinase, catalytic domain |
| UnnamedSample_HQ_transcript/64511|m.16947 | UnnamedSample_HQ_transcript/64511 | Unmapped. | c5284e78ffbcd7496c5f35078232ddb8 | 113 | Pfam | PF05485 | THAP domain | 5 | 96 | 2.7E-15 | T | 22-09-2020 | IPR006612 | THAP-type zinc finger |
| UnnamedSample_HQ_transcript/18126|m.6341 | UnnamedSample_HQ_transcript/18126 | Coverage 0.040 too low. | cf6bbeeecc5e7702b59f9d73f1697375 | 464 | Pfam | PF00105 | Zinc finger, C4 type (two domains) | 128 | 196 | 8.7E-31 | T | 22-09-2020 | IPR001628 | Zinc finger, nuclear hormone receptor-type |
| UnnamedSample_HQ_transcript/18126|m.6341 | UnnamedSample_HQ_transcript/18126 | Coverage 0.040 too low. | cf6bbeeecc5e7702b59f9d73f1697375 | 464 | Pfam | PF00104 | Ligand-binding domain of nuclear hormone receptor | 270 | 433 | 8.3E-22 | T | 22-09-2020 | IPR000536 | Nuclear hormone receptor, ligand-binding domain |
| UnnamedSample_HQ_transcript/67893|m.17562 | UnnamedSample_HQ_transcript/67893 | Coverage 0.635 too low. | cf6bbeeecc5e7702b59f9d73f1697375 | 464 | Pfam | PF00105 | Zinc finger, C4 type (two domains) | 128 | 196 | 8.7E-31 | T | 22-09-2020 | IPR001628 | Zinc finger, nuclear hormone receptor-type |
| UnnamedSample_HQ_transcript/67893|m.17562 | UnnamedSample_HQ_transcript/67893 | Coverage 0.635 too low. | cf6bbeeecc5e7702b59f9d73f1697375 | 464 | Pfam | PF00104 | Ligand-binding domain of nuclear hormone receptor | 270 | 433 | 8.3E-22 | T | 22-09-2020 | IPR000536 | Nuclear hormone receptor, ligand-binding domain |
| UnnamedSample_HQ_transcript/52070|m.14472 | UnnamedSample_HQ_transcript/52070 | Coverage 0.568 too low. | cf6bbeeecc5e7702b59f9d73f1697375 | 464 | Pfam | PF00105 | Zinc finger, C4 type (two domains) | 128 | 196 | 8.7E-31 | T | 22-09-2020 | IPR001628 | Zinc finger, nuclear hormone receptor-type |
| UnnamedSample_HQ_transcript/52070|m.14472 | UnnamedSample_HQ_transcript/52070 | Coverage 0.568 too low. | cf6bbeeecc5e7702b59f9d73f1697375 | 464 | Pfam | PF00104 | Ligand-binding domain of nuclear hormone receptor | 270 | 433 | 8.3E-22 | T | 22-09-2020 | IPR000536 | Nuclear hormone receptor, ligand-binding domain |
| UnnamedSample_HQ_transcript/3948|m.1789 | UnnamedSample_HQ_transcript/3948 | Coverage 0.295 too low. | 8bf94767d6931b98430c751cfc8993d5 | 899 | Pfam | PF00514 | Armadillo/beta-catenin-like repeat | 281 | 320 | 2.9E-9 | T | 22-09-2020 | IPR000225 | Armadillo |
| UnnamedSample_HQ_transcript/3948|m.1789 | UnnamedSample_HQ_transcript/3948 | Coverage 0.295 too low. | 8bf94767d6931b98430c751cfc8993d5 | 899 | Pfam | PF00514 | Armadillo/beta-catenin-like repeat | 539 | 574 | 4.9E-6 | T | 22-09-2020 | IPR000225 | Armadillo |
| UnnamedSample_HQ_transcript/3948|m.1789 | UnnamedSample_HQ_transcript/3948 | Coverage 0.295 too low. | 8bf94767d6931b98430c751cfc8993d5 | 899 | Pfam | PF00514 | Armadillo/beta-catenin-like repeat | 582 | 619 | 9.2E-6 | T | 22-09-2020 | IPR000225 | Armadillo |
| UnnamedSample_HQ_transcript/3948|m.1789 | UnnamedSample_HQ_transcript/3948 | Coverage 0.295 too low. | 8bf94767d6931b98430c751cfc8993d5 | 899 | Pfam | PF00514 | Armadillo/beta-catenin-like repeat | 325 | 366 | 9.9E-7 | T | 22-09-2020 | IPR000225 | Armadillo |
| UnnamedSample_HQ_transcript/9128|m.3555 | UnnamedSample_HQ_transcript/9128 | Coverage 0.672 too low. | d3a0b61df17e71cd0159e57881ba18e7 | 336 | Pfam | PF03564 | Protein of unknown function (DUF1759) | 165 | 305 | 1.2E-17 | T | 22-09-2020 | IPR005312 | Protein of unknown function DUF1759 |
| UnnamedSample_HQ_transcript/21675|m.7336 | UnnamedSample_HQ_transcript/21675 | Coverage 0.111 too low. | fd1915fe586506c60666be28797205a5 | 355 | Pfam | PF18124 | Kindlin-2 N-terminal domain | 9 | 50 | 1.4E-10 | T | 22-09-2020 | IPR040790 | Kindlin-2, N-terminal |
| UnnamedSample_HQ_transcript/21675|m.7336 | UnnamedSample_HQ_transcript/21675 | Coverage 0.111 too low. | fd1915fe586506c60666be28797205a5 | 355 | Pfam | PF00373 | FERM central domain | 223 | 307 | 8.8E-17 | T | 22-09-2020 | IPR019748 | FERM central domain |
| UnnamedSample_HQ_transcript/35756|m.10871 | UnnamedSample_HQ_transcript/35756 | Coverage 0.980 too low. | a476318cdc9985f229a2e0638a2a0650 | 770 | Pfam | PF12513 | Mitochondrial degradasome RNA helicase subunit C terminal | 614 | 659 | 2.3E-14 | T | 22-09-2020 | IPR022192 | Mitochondrial degradasome RNA helicase subunit, C-terminal domain |
| UnnamedSample_HQ_transcript/35756|m.10871 | UnnamedSample_HQ_transcript/35756 | Coverage 0.980 too low. | a476318cdc9985f229a2e0638a2a0650 | 770 | Pfam | PF18147 | Suv3 C-terminal domain 1 | 546 | 587 | 7.8E-15 | T | 22-09-2020 | IPR041082 | Suv3, C-terminal domain 1 |
| UnnamedSample_HQ_transcript/35756|m.10871 | UnnamedSample_HQ_transcript/35756 | Coverage 0.980 too low. | a476318cdc9985f229a2e0638a2a0650 | 770 | Pfam | PF18114 | Suv3 helical N-terminal domain | 51 | 167 | 1.5E-38 | T | 22-09-2020 | IPR041453 | Suv3, N-terminal |
| UnnamedSample_HQ_transcript/35756|m.10871 | UnnamedSample_HQ_transcript/35756 | Coverage 0.980 too low. | a476318cdc9985f229a2e0638a2a0650 | 770 | Pfam | PF00271 | Helicase conserved C-terminal domain | 357 | 463 | 9.0E-12 | T | 22-09-2020 | IPR001650 | Helicase, C-terminal |
| UnnamedSample_HQ_transcript/46790|m.13321 | UnnamedSample_HQ_transcript/46790 | Identity 0.938 too low. | 00408c5cb1a33f28f6a21c56ea5d5213 | 639 | Pfam | PF00856 | SET domain | 237 | 519 | 2.6E-12 | T | 22-09-2020 | IPR001214 | SET domain |
| UnnamedSample_HQ_transcript/24690|m.8128 | UnnamedSample_HQ_transcript/24690 | Coverage 0.069 too low. | d6209d599bf955362e59d0fa5f312d24 | 328 | Pfam | PF01019 | Gamma-glutamyltranspeptidase | 1 | 323 | 7.9E-91 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/83051|m.20206 | UnnamedSample_HQ_transcript/83051 | Coverage 0.162 too low. | 1eecc4b88a6b764262d223b73a43b528 | 320 | Pfam | PF02773 | S-adenosylmethionine synthetase, C-terminal domain | 177 | 314 | 2.8E-67 | T | 22-09-2020 | IPR022630 | S-adenosylmethionine synthetase, C-terminal |
| UnnamedSample_HQ_transcript/83051|m.20206 | UnnamedSample_HQ_transcript/83051 | Coverage 0.162 too low. | 1eecc4b88a6b764262d223b73a43b528 | 320 | Pfam | PF02772 | S-adenosylmethionine synthetase, central domain | 61 | 175 | 6.1E-41 | T | 22-09-2020 | IPR022629 | S-adenosylmethionine synthetase, central domain |
| UnnamedSample_HQ_transcript/91482|m.21470 | UnnamedSample_HQ_transcript/91482 | Unmapped. | 83b021e76ea131e6509756d3ce551eaa | 276 | Pfam | PF00459 | Inositol monophosphatase family | 5 | 268 | 8.7E-77 | T | 22-09-2020 | IPR000760 | Inositol monophosphatase-like |
| UnnamedSample_HQ_transcript/95973|m.22084 | UnnamedSample_HQ_transcript/95973 | Unmapped. | 83b021e76ea131e6509756d3ce551eaa | 276 | Pfam | PF00459 | Inositol monophosphatase family | 5 | 268 | 8.7E-77 | T | 22-09-2020 | IPR000760 | Inositol monophosphatase-like |
| UnnamedSample_HQ_transcript/95234|m.21987 | UnnamedSample_HQ_transcript/95234 | Unmapped. | 83b021e76ea131e6509756d3ce551eaa | 276 | Pfam | PF00459 | Inositol monophosphatase family | 5 | 268 | 8.7E-77 | T | 22-09-2020 | IPR000760 | Inositol monophosphatase-like |
| UnnamedSample_HQ_transcript/100412|m.22699 | UnnamedSample_HQ_transcript/100412 | Unmapped. | 83b021e76ea131e6509756d3ce551eaa | 276 | Pfam | PF00459 | Inositol monophosphatase family | 5 | 268 | 8.7E-77 | T | 22-09-2020 | IPR000760 | Inositol monophosphatase-like |
| UnnamedSample_HQ_transcript/90808|m.21378 | UnnamedSample_HQ_transcript/90808 | Unmapped. | 83b021e76ea131e6509756d3ce551eaa | 276 | Pfam | PF00459 | Inositol monophosphatase family | 5 | 268 | 8.7E-77 | T | 22-09-2020 | IPR000760 | Inositol monophosphatase-like |
| UnnamedSample_HQ_transcript/95175|m.21979 | UnnamedSample_HQ_transcript/95175 | Unmapped. | 83b021e76ea131e6509756d3ce551eaa | 276 | Pfam | PF00459 | Inositol monophosphatase family | 5 | 268 | 8.7E-77 | T | 22-09-2020 | IPR000760 | Inositol monophosphatase-like |
| UnnamedSample_HQ_transcript/100074|m.22652 | UnnamedSample_HQ_transcript/100074 | Coverage 0.989 too low. | ef882723cd23c8ec36166c776949c555 | 141 | Pfam | PF06179 | Surfeit locus protein 5 subunit 22 of Mediator complex | 21 | 124 | 2.5E-33 | T | 22-09-2020 | IPR009332 | Mediator of RNA polymerase II transcription subunit 22 |
| UnnamedSample_HQ_transcript/35186|m.10753 | UnnamedSample_HQ_transcript/35186 | Identity 0.937 too low. | 8495d758cec2e3614e9f014fe16be53a | 383 | Pfam | PF05485 | THAP domain | 72 | 137 | 9.7E-10 | T | 22-09-2020 | IPR006612 | THAP-type zinc finger |
| UnnamedSample_HQ_transcript/23177|m.7733 | UnnamedSample_HQ_transcript/23177 | Unmapped. | 16c97f2b31e36edeb39eeed33505e6d1 | 603 | Pfam | PF13087 | AAA domain | 452 | 597 | 9.8E-18 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/23177|m.7733 | UnnamedSample_HQ_transcript/23177 | Unmapped. | 16c97f2b31e36edeb39eeed33505e6d1 | 603 | Pfam | PF13086 | AAA domain | 269 | 339 | 2.2E-9 | T | 22-09-2020 | IPR041677 | DNA2/NAM7 helicase, helicase domain |
| UnnamedSample_HQ_transcript/22176|m.7479 | UnnamedSample_HQ_transcript/22176 | Coverage 0.039 too low. | c8322aaf72e1bc0875186d306b88b0c4 | 861 | Pfam | PF17751 | SKICH domain | 49 | 143 | 3.6E-7 | T | 22-09-2020 | IPR041611 | SKICH domain |
| UnnamedSample_HQ_transcript/39638|m.11768 | UnnamedSample_HQ_transcript/39638 | Coverage 0.877 too low. | 04988995ef84ad6064b331a4eae3a5c7 | 410 | Pfam | PF00806 | Pumilio-family RNA binding repeat | 247 | 268 | 1.8E-5 | T | 22-09-2020 | IPR001313 | Pumilio RNA-binding repeat |
| UnnamedSample_HQ_transcript/39638|m.11768 | UnnamedSample_HQ_transcript/39638 | Coverage 0.877 too low. | 04988995ef84ad6064b331a4eae3a5c7 | 410 | Pfam | PF00806 | Pumilio-family RNA binding repeat | 209 | 242 | 5.5E-11 | T | 22-09-2020 | IPR001313 | Pumilio RNA-binding repeat |
| UnnamedSample_HQ_transcript/20925|m.7130 | UnnamedSample_HQ_transcript/20925 | Coverage 0.152 too low. | 48b65dd746cec062c37cbe68c7b3a051 | 548 | Pfam | PF00567 | Tudor domain | 245 | 357 | 1.9E-23 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/20925|m.7130 | UnnamedSample_HQ_transcript/20925 | Coverage 0.152 too low. | 48b65dd746cec062c37cbe68c7b3a051 | 548 | Pfam | PF00567 | Tudor domain | 73 | 177 | 2.2E-14 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/24269|m.8014 | UnnamedSample_HQ_transcript/24269 | Coverage 0.160 too low. | 48b65dd746cec062c37cbe68c7b3a051 | 548 | Pfam | PF00567 | Tudor domain | 245 | 357 | 1.9E-23 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/24269|m.8014 | UnnamedSample_HQ_transcript/24269 | Coverage 0.160 too low. | 48b65dd746cec062c37cbe68c7b3a051 | 548 | Pfam | PF00567 | Tudor domain | 73 | 177 | 2.2E-14 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/14636|m.5302 | UnnamedSample_HQ_transcript/14636 | Identity 0.909 too low. | 8c36e24178a80d63f1e2ea7cf0e646a0 | 604 | Pfam | PF12901 | SUZ-C motif | 578 | 595 | 1.3E-6 | T | 22-09-2020 | IPR024642 | SUZ-C domain |
| UnnamedSample_HQ_transcript/14636|m.5302 | UnnamedSample_HQ_transcript/14636 | Identity 0.909 too low. | 8c36e24178a80d63f1e2ea7cf0e646a0 | 604 | Pfam | PF05383 | La domain | 136 | 193 | 9.0E-22 | T | 22-09-2020 | IPR006630 | La-type HTH domain |
| UnnamedSample_HQ_transcript/43078|m.12506 | UnnamedSample_HQ_transcript/43078 | Coverage 0.940 too low. | b69448a4c5c31fc1cabf774391ad372e | 530 | Pfam | PF00201 | UDP-glucoronosyl and UDP-glucosyl transferase | 51 | 510 | 3.3E-84 | T | 22-09-2020 | IPR002213 | UDP-glucuronosyl/UDP-glucosyltransferase |
| UnnamedSample_HQ_transcript/83250|m.20233 | UnnamedSample_HQ_transcript/83250 | Coverage 0.138 too low. | 986c34addd9c63e8abdc1624cd1a2c28 | 365 | Pfam | PF01285 | TEA/ATTS domain | 2 | 32 | 2.0E-13 | T | 22-09-2020 | IPR000818 | TEA/ATTS domain |
| UnnamedSample_HQ_transcript/83250|m.20233 | UnnamedSample_HQ_transcript/83250 | Coverage 0.138 too low. | 986c34addd9c63e8abdc1624cd1a2c28 | 365 | Pfam | PF17725 | YAP binding domain | 157 | 334 | 1.7E-68 | T | 22-09-2020 | IPR041086 | YAP binding domain |
| UnnamedSample_HQ_transcript/102914|m.22978 | UnnamedSample_HQ_transcript/102914 | Coverage 0.222 too low. | 1800861d6957517630a71b1f54834950 | 207 | Pfam | PF00080 | Copper/zinc superoxide dismutase (SODC) | 36 | 171 | 4.9E-46 | T | 22-09-2020 | IPR001424 | Superoxide dismutase, copper/zinc binding domain |
| UnnamedSample_HQ_transcript/108348|m.23621 | UnnamedSample_HQ_transcript/108348 | Coverage 0.091 too low. | 1800861d6957517630a71b1f54834950 | 207 | Pfam | PF00080 | Copper/zinc superoxide dismutase (SODC) | 36 | 171 | 4.9E-46 | T | 22-09-2020 | IPR001424 | Superoxide dismutase, copper/zinc binding domain |
| UnnamedSample_HQ_transcript/95164|m.21978 | UnnamedSample_HQ_transcript/95164 | Coverage 0.530 too low. | 5c71d1a7c8b97c5512d73310bc68d754 | 273 | Pfam | PF07686 | Immunoglobulin V-set domain | 37 | 132 | 2.9E-8 | T | 22-09-2020 | IPR013106 | Immunoglobulin V-set domain |
| UnnamedSample_HQ_transcript/95164|m.21978 | UnnamedSample_HQ_transcript/95164 | Coverage 0.530 too low. | 5c71d1a7c8b97c5512d73310bc68d754 | 273 | Pfam | PF08205 | CD80-like C2-set immunoglobulin domain | 141 | 184 | 8.1E-5 | T | 22-09-2020 | IPR013162 | CD80-like, immunoglobulin C2-set |
| UnnamedSample_HQ_transcript/637|m.457 | UnnamedSample_HQ_transcript/637 | Coverage 0.863 too low. | 07d5bbc3d3503f9b602b037e88e2dafc | 2240 | Pfam | PF06333 | Mediator complex subunit 13 C-terminal domain | 1794 | 2156 | 9.2E-82 | T | 22-09-2020 | IPR009401 | Mediator complex subunit Med13, C-terminal |
| UnnamedSample_HQ_transcript/637|m.457 | UnnamedSample_HQ_transcript/637 | Coverage 0.863 too low. | 07d5bbc3d3503f9b602b037e88e2dafc | 2240 | Pfam | PF18296 | MID domain of medPIWI | 1480 | 1756 | 6.9E-71 | T | 22-09-2020 | IPR041285 | MID domain of medPIWI |
| UnnamedSample_HQ_transcript/65577|m.17126 | UnnamedSample_HQ_transcript/65577 | Coverage 0.644 too low. | 7e1c4615cec4ac5190c13114cd50b885 | 447 | Pfam | PF00351 | Biopterin-dependent aromatic amino acid hydroxylase | 115 | 444 | 2.7E-175 | T | 22-09-2020 | IPR019774 | Aromatic amino acid hydroxylase, C-terminal |
| UnnamedSample_HQ_transcript/77140|m.19226 | UnnamedSample_HQ_transcript/77140 | Coverage 0.580 too low. | 7e1c4615cec4ac5190c13114cd50b885 | 447 | Pfam | PF00351 | Biopterin-dependent aromatic amino acid hydroxylase | 115 | 444 | 2.7E-175 | T | 22-09-2020 | IPR019774 | Aromatic amino acid hydroxylase, C-terminal |
| UnnamedSample_HQ_transcript/77784|m.19337 | UnnamedSample_HQ_transcript/77784 | Coverage 0.626 too low. | 7e1c4615cec4ac5190c13114cd50b885 | 447 | Pfam | PF00351 | Biopterin-dependent aromatic amino acid hydroxylase | 115 | 444 | 2.7E-175 | T | 22-09-2020 | IPR019774 | Aromatic amino acid hydroxylase, C-terminal |
| UnnamedSample_HQ_transcript/69342|m.17819 | UnnamedSample_HQ_transcript/69342 | Coverage 0.662 too low. | 7e1c4615cec4ac5190c13114cd50b885 | 447 | Pfam | PF00351 | Biopterin-dependent aromatic amino acid hydroxylase | 115 | 444 | 2.7E-175 | T | 22-09-2020 | IPR019774 | Aromatic amino acid hydroxylase, C-terminal |
| UnnamedSample_HQ_transcript/72549|m.18391 | UnnamedSample_HQ_transcript/72549 | Coverage 0.606 too low. | 7e1c4615cec4ac5190c13114cd50b885 | 447 | Pfam | PF00351 | Biopterin-dependent aromatic amino acid hydroxylase | 115 | 444 | 2.7E-175 | T | 22-09-2020 | IPR019774 | Aromatic amino acid hydroxylase, C-terminal |
| UnnamedSample_HQ_transcript/5285|m.2290 | UnnamedSample_HQ_transcript/5285 | Coverage 0.072 too low. | 3dca521b3e4998817a705c9499f57405 | 1456 | Pfam | PF00595 | PDZ domain | 755 | 837 | 1.2E-12 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/5285|m.2290 | UnnamedSample_HQ_transcript/5285 | Coverage 0.072 too low. | 3dca521b3e4998817a705c9499f57405 | 1456 | Pfam | PF00536 | SAM domain (Sterile alpha motif) | 1381 | 1439 | 5.7E-11 | T | 22-09-2020 | IPR001660 | Sterile alpha motif domain |
| UnnamedSample_HQ_transcript/5285|m.2290 | UnnamedSample_HQ_transcript/5285 | Coverage 0.072 too low. | 3dca521b3e4998817a705c9499f57405 | 1456 | Pfam | PF17817 | PDZ domain | 674 | 746 | 2.3E-33 | T | 22-09-2020 | IPR040645 | Neurabin-1/2, PDZ domain |
| UnnamedSample_HQ_transcript/67185|m.17440 | UnnamedSample_HQ_transcript/67185 | Coverage 0.922 too low. | cdf928e332edaa859895299112730d7d | 250 | Pfam | PF00233 | 3'5'-cyclic nucleotide phosphodiesterase | 1 | 222 | 6.4E-68 | T | 22-09-2020 | IPR002073 | 3'5'-cyclic nucleotide phosphodiesterase, catalytic domain |
| UnnamedSample_HQ_transcript/15047|m.5413 | UnnamedSample_HQ_transcript/15047 | Coverage 0.826 too low. | ea26d8d81300ea326232c112694b59d1 | 1051 | Pfam | PF00630 | Filamin/ABP280 repeat | 79 | 163 | 4.5E-9 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/15047|m.5413 | UnnamedSample_HQ_transcript/15047 | Coverage 0.826 too low. | ea26d8d81300ea326232c112694b59d1 | 1051 | Pfam | PF00630 | Filamin/ABP280 repeat | 547 | 633 | 1.2E-11 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/15047|m.5413 | UnnamedSample_HQ_transcript/15047 | Coverage 0.826 too low. | ea26d8d81300ea326232c112694b59d1 | 1051 | Pfam | PF00630 | Filamin/ABP280 repeat | 924 | 1013 | 4.7E-17 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/15047|m.5413 | UnnamedSample_HQ_transcript/15047 | Coverage 0.826 too low. | ea26d8d81300ea326232c112694b59d1 | 1051 | Pfam | PF00630 | Filamin/ABP280 repeat | 830 | 916 | 8.6E-12 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/15047|m.5413 | UnnamedSample_HQ_transcript/15047 | Coverage 0.826 too low. | ea26d8d81300ea326232c112694b59d1 | 1051 | Pfam | PF00630 | Filamin/ABP280 repeat | 174 | 259 | 2.1E-9 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/15047|m.5413 | UnnamedSample_HQ_transcript/15047 | Coverage 0.826 too low. | ea26d8d81300ea326232c112694b59d1 | 1051 | Pfam | PF00630 | Filamin/ABP280 repeat | 737 | 822 | 3.1E-10 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/15047|m.5413 | UnnamedSample_HQ_transcript/15047 | Coverage 0.826 too low. | ea26d8d81300ea326232c112694b59d1 | 1051 | Pfam | PF00630 | Filamin/ABP280 repeat | 264 | 349 | 8.7E-7 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/15047|m.5413 | UnnamedSample_HQ_transcript/15047 | Coverage 0.826 too low. | ea26d8d81300ea326232c112694b59d1 | 1051 | Pfam | PF00630 | Filamin/ABP280 repeat | 363 | 444 | 1.6E-7 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/53949|m.14827 | UnnamedSample_HQ_transcript/53949 | Coverage 0.487 too low. | 349732f2bd2cfc2fe8ee4b328d238a80 | 399 | Pfam | PF07766 | LETM1-like protein | 1 | 184 | 4.5E-63 | T | 22-09-2020 | IPR011685 | LETM1-like |
| UnnamedSample_HQ_transcript/95339|m.22007 | UnnamedSample_HQ_transcript/95339 | Coverage 0.835 too low. | 349732f2bd2cfc2fe8ee4b328d238a80 | 399 | Pfam | PF07766 | LETM1-like protein | 1 | 184 | 4.5E-63 | T | 22-09-2020 | IPR011685 | LETM1-like |
| UnnamedSample_HQ_transcript/68685|m.17703 | UnnamedSample_HQ_transcript/68685 | Coverage 0.582 too low. | 12df27c744c3741e4c878e3b83de6be1 | 537 | Pfam | PF03160 | Calx-beta domain | 464 | 536 | 4.9E-14 | T | 22-09-2020 | IPR003644 | Na-Ca exchanger/integrin-beta4 |
| UnnamedSample_HQ_transcript/68685|m.17703 | UnnamedSample_HQ_transcript/68685 | Coverage 0.582 too low. | 12df27c744c3741e4c878e3b83de6be1 | 537 | Pfam | PF03160 | Calx-beta domain | 354 | 446 | 6.2E-22 | T | 22-09-2020 | IPR003644 | Na-Ca exchanger/integrin-beta4 |
| UnnamedSample_HQ_transcript/68685|m.17703 | UnnamedSample_HQ_transcript/68685 | Coverage 0.582 too low. | 12df27c744c3741e4c878e3b83de6be1 | 537 | Pfam | PF01699 | Sodium/calcium exchanger protein | 41 | 226 | 1.1E-24 | T | 22-09-2020 | IPR004837 | Sodium/calcium exchanger membrane region |
| UnnamedSample_HQ_transcript/6561|m.2726 | UnnamedSample_HQ_transcript/6561 | Coverage 0.949 too low. | b66b72bfb8d7b95b62ce9fbe6f5f810c | 360 | Pfam | PF10267 | Predicted transmembrane and coiled-coil 2 protein | 1 | 333 | 1.1E-107 | T | 22-09-2020 | IPR019394 | Testis-specific protein TEX28/transmembrane and coiled-coil domains protein |
| UnnamedSample_HQ_transcript/10746|m.4062 | UnnamedSample_HQ_transcript/10746 | Coverage 0.985 too low. | 6f053cf9d962279aa73b7cc2d67a4c99 | 843 | Pfam | PF07714 | Protein tyrosine and serine/threonine kinase | 4 | 228 | 5.1E-46 | T | 22-09-2020 | IPR001245 | Serine-threonine/tyrosine-protein kinase, catalytic domain |
| UnnamedSample_HQ_transcript/29022|m.9233 | UnnamedSample_HQ_transcript/29022 | Coverage 0.760 too low. | 0ca5fe7e5ac7d870ffc486884278b5fa | 402 | Pfam | PF00412 | LIM domain | 192 | 251 | 1.2E-10 | T | 22-09-2020 | IPR001781 | Zinc finger, LIM-type |
| UnnamedSample_HQ_transcript/29022|m.9233 | UnnamedSample_HQ_transcript/29022 | Coverage 0.760 too low. | 0ca5fe7e5ac7d870ffc486884278b5fa | 402 | Pfam | PF00412 | LIM domain | 257 | 311 | 6.2E-13 | T | 22-09-2020 | IPR001781 | Zinc finger, LIM-type |
| UnnamedSample_HQ_transcript/29022|m.9233 | UnnamedSample_HQ_transcript/29022 | Coverage 0.760 too low. | 0ca5fe7e5ac7d870ffc486884278b5fa | 402 | Pfam | PF00412 | LIM domain | 317 | 369 | 3.3E-5 | T | 22-09-2020 | IPR001781 | Zinc finger, LIM-type |
| UnnamedSample_HQ_transcript/29022|m.9233 | UnnamedSample_HQ_transcript/29022 | Coverage 0.760 too low. | 0ca5fe7e5ac7d870ffc486884278b5fa | 402 | Pfam | PF06297 | PET Domain | 100 | 184 | 3.4E-36 | T | 22-09-2020 | IPR010442 | PET domain |
| UnnamedSample_HQ_transcript/86089|m.20668 | UnnamedSample_HQ_transcript/86089 | Coverage 0.700 too low. | f4052dfe1b2112bd8ce893eff1fa9fb2 | 425 | Pfam | PF03914 | CBF/Mak21 family | 189 | 341 | 1.7E-24 | T | 22-09-2020 | IPR005612 | CCAAT-binding factor |
| UnnamedSample_HQ_transcript/13774|m.5041 | UnnamedSample_HQ_transcript/13774 | Coverage 0.902 too low. | 215ff017947f1130c468d5a33f788709 | 1053 | Pfam | PF16294 | RNSP1-SAP18 binding (RSB) motif | 930 | 1017 | 1.2E-21 | T | 22-09-2020 | IPR032552 | Acin1, RNSP1-SAP18 binding (RSB) motif |
| UnnamedSample_HQ_transcript/93070|m.21676 | UnnamedSample_HQ_transcript/93070 | Identity 0.882 too low. | d93a984eb9be9844d83c9f96488ed00e | 352 | Pfam | PF01299 | Lysosome-associated membrane glycoprotein (Lamp) | 146 | 295 | 6.7E-16 | T | 22-09-2020 | IPR002000 | Lysosome-associated membrane glycoprotein |
| UnnamedSample_HQ_transcript/42521|m.12377 | UnnamedSample_HQ_transcript/42521 | Identity 0.934 too low. | d93a984eb9be9844d83c9f96488ed00e | 352 | Pfam | PF01299 | Lysosome-associated membrane glycoprotein (Lamp) | 146 | 295 | 6.7E-16 | T | 22-09-2020 | IPR002000 | Lysosome-associated membrane glycoprotein |
| UnnamedSample_HQ_transcript/57471|m.15543 | UnnamedSample_HQ_transcript/57471 | Coverage 0.652 too low. | 0ecd8f9ccd82fc0c90a6ad7f52fe5ad2 | 431 | Pfam | PF12937 | F-box-like | 5 | 48 | 1.1E-7 | T | 22-09-2020 | IPR001810 | F-box domain |
| UnnamedSample_HQ_transcript/71247|m.18158 | UnnamedSample_HQ_transcript/71247 | Coverage 0.731 too low. | 0ecd8f9ccd82fc0c90a6ad7f52fe5ad2 | 431 | Pfam | PF12937 | F-box-like | 5 | 48 | 1.1E-7 | T | 22-09-2020 | IPR001810 | F-box domain |
| UnnamedSample_HQ_transcript/78389|m.19443 | UnnamedSample_HQ_transcript/78389 | Coverage 0.247 too low. | 34096353ece84f3d7b6a0b9eefcdec6c | 277 | Pfam | PF06585 | Haemolymph juvenile hormone binding protein (JHBP) | 11 | 246 | 1.2E-67 | T | 22-09-2020 | IPR010562 | Haemolymph juvenile hormone binding |
| UnnamedSample_HQ_transcript/116086|m.24500 | UnnamedSample_HQ_transcript/116086 | Coverage 0.735 too low. | 432a14485d07a3e423740c8fe4729eaa | 186 | Pfam | PF00012 | Hsp70 protein | 6 | 185 | 2.2E-91 | T | 22-09-2020 | IPR013126 | Heat shock protein 70 family |
| UnnamedSample_HQ_transcript/14994|m.5397 | UnnamedSample_HQ_transcript/14994 | Coverage 0.889 too low. | 776107dd0dae1e5c51ebde0a03320aa7 | 948 | Pfam | PF08623 | TATA-binding protein interacting (TIP20) | 755 | 918 | 1.0E-62 | T | 22-09-2020 | IPR013932 | TATA-binding protein interacting (TIP20) |
| UnnamedSample_HQ_transcript/5023|m.2207 | UnnamedSample_HQ_transcript/5023 | Coverage 0.449 too low. | 40ed96053b7b3fb4af17e930eb01b0b6 | 1022 | Pfam | PF17917 | RNase H-like domain found in reverse transcriptase | 799 | 903 | 4.3E-30 | T | 22-09-2020 | IPR041373 | Reverse transcriptase, RNase H-like domain |
| UnnamedSample_HQ_transcript/5023|m.2207 | UnnamedSample_HQ_transcript/5023 | Coverage 0.449 too low. | 40ed96053b7b3fb4af17e930eb01b0b6 | 1022 | Pfam | PF00078 | Reverse transcriptase (RNA-dependent DNA polymerase) | 554 | 712 | 1.1E-23 | T | 22-09-2020 | IPR000477 | Reverse transcriptase domain |
| UnnamedSample_HQ_transcript/10936|m.4127 | UnnamedSample_HQ_transcript/10936 | Coverage 0.649 too low. | 72e8ad0e4441a7f725c8d060fe8fa188 | 894 | Pfam | PF00096 | Zinc finger, C2H2 type | 775 | 797 | 0.0011 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/20580|m.7029 | UnnamedSample_HQ_transcript/20580 | Coverage 0.783 too low. | 72e8ad0e4441a7f725c8d060fe8fa188 | 894 | Pfam | PF00096 | Zinc finger, C2H2 type | 775 | 797 | 0.0011 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/22518|m.7578 | UnnamedSample_HQ_transcript/22518 | Coverage 0.802 too low. | 72e8ad0e4441a7f725c8d060fe8fa188 | 894 | Pfam | PF00096 | Zinc finger, C2H2 type | 775 | 797 | 0.0011 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/25443|m.8332 | UnnamedSample_HQ_transcript/25443 | Coverage 0.865 too low. | 64702cca412640fd40a83bad9447aaff | 417 | Pfam | PF00069 | Protein kinase domain | 12 | 270 | 1.7E-40 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/112852|m.24170 | UnnamedSample_HQ_transcript/112852 | Coverage 0.915 too low. | 6def00edafe1ed0cb13962f322e9440e | 220 | Pfam | PF02096 | 60Kd inner membrane protein | 3 | 131 | 1.5E-15 | T | 22-09-2020 | IPR001708 | Membrane insertase YidC/ALB3/OXA1/COX18 |
| UnnamedSample_HQ_transcript/952|m.612 | UnnamedSample_HQ_transcript/952 | Coverage 0.950 too low. | 7a62976ab83eedb9103038639545667f | 2090 | Pfam | PF00435 | Spectrin repeat | 954 | 1057 | 4.9E-17 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/952|m.612 | UnnamedSample_HQ_transcript/952 | Coverage 0.950 too low. | 7a62976ab83eedb9103038639545667f | 2090 | Pfam | PF00435 | Spectrin repeat | 1699 | 1801 | 4.9E-22 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/952|m.612 | UnnamedSample_HQ_transcript/952 | Coverage 0.950 too low. | 7a62976ab83eedb9103038639545667f | 2090 | Pfam | PF00435 | Spectrin repeat | 299 | 407 | 3.3E-12 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/952|m.612 | UnnamedSample_HQ_transcript/952 | Coverage 0.950 too low. | 7a62976ab83eedb9103038639545667f | 2090 | Pfam | PF00435 | Spectrin repeat | 1170 | 1266 | 2.4E-12 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/952|m.612 | UnnamedSample_HQ_transcript/952 | Coverage 0.950 too low. | 7a62976ab83eedb9103038639545667f | 2090 | Pfam | PF00435 | Spectrin repeat | 524 | 633 | 7.4E-14 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/952|m.612 | UnnamedSample_HQ_transcript/952 | Coverage 0.950 too low. | 7a62976ab83eedb9103038639545667f | 2090 | Pfam | PF00435 | Spectrin repeat | 636 | 738 | 5.5E-25 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/952|m.612 | UnnamedSample_HQ_transcript/952 | Coverage 0.950 too low. | 7a62976ab83eedb9103038639545667f | 2090 | Pfam | PF00435 | Spectrin repeat | 1276 | 1376 | 1.8E-16 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/952|m.612 | UnnamedSample_HQ_transcript/952 | Coverage 0.950 too low. | 7a62976ab83eedb9103038639545667f | 2090 | Pfam | PF00435 | Spectrin repeat | 742 | 843 | 1.2E-22 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/952|m.612 | UnnamedSample_HQ_transcript/952 | Coverage 0.950 too low. | 7a62976ab83eedb9103038639545667f | 2090 | Pfam | PF00435 | Spectrin repeat | 2019 | 2077 | 1.7E-11 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/952|m.612 | UnnamedSample_HQ_transcript/952 | Coverage 0.950 too low. | 7a62976ab83eedb9103038639545667f | 2090 | Pfam | PF00435 | Spectrin repeat | 1806 | 1908 | 5.8E-19 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/952|m.612 | UnnamedSample_HQ_transcript/952 | Coverage 0.950 too low. | 7a62976ab83eedb9103038639545667f | 2090 | Pfam | PF00435 | Spectrin repeat | 1594 | 1696 | 7.2E-19 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/952|m.612 | UnnamedSample_HQ_transcript/952 | Coverage 0.950 too low. | 7a62976ab83eedb9103038639545667f | 2090 | Pfam | PF00435 | Spectrin repeat | 1060 | 1166 | 5.8E-18 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/952|m.612 | UnnamedSample_HQ_transcript/952 | Coverage 0.950 too low. | 7a62976ab83eedb9103038639545667f | 2090 | Pfam | PF00435 | Spectrin repeat | 848 | 949 | 1.4E-18 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/952|m.612 | UnnamedSample_HQ_transcript/952 | Coverage 0.950 too low. | 7a62976ab83eedb9103038639545667f | 2090 | Pfam | PF00435 | Spectrin repeat | 1386 | 1483 | 9.7E-16 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/952|m.612 | UnnamedSample_HQ_transcript/952 | Coverage 0.950 too low. | 7a62976ab83eedb9103038639545667f | 2090 | Pfam | PF00435 | Spectrin repeat | 1912 | 2014 | 2.2E-19 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/952|m.612 | UnnamedSample_HQ_transcript/952 | Coverage 0.950 too low. | 7a62976ab83eedb9103038639545667f | 2090 | Pfam | PF00435 | Spectrin repeat | 419 | 520 | 1.1E-16 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/952|m.612 | UnnamedSample_HQ_transcript/952 | Coverage 0.950 too low. | 7a62976ab83eedb9103038639545667f | 2090 | Pfam | PF00435 | Spectrin repeat | 1487 | 1589 | 9.5E-21 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/952|m.612 | UnnamedSample_HQ_transcript/952 | Coverage 0.950 too low. | 7a62976ab83eedb9103038639545667f | 2090 | Pfam | PF00307 | Calponin homology (CH) domain | 49 | 152 | 1.0E-19 | T | 22-09-2020 | IPR001715 | Calponin homology domain |
| UnnamedSample_HQ_transcript/952|m.612 | UnnamedSample_HQ_transcript/952 | Coverage 0.950 too low. | 7a62976ab83eedb9103038639545667f | 2090 | Pfam | PF00307 | Calponin homology (CH) domain | 169 | 273 | 2.9E-26 | T | 22-09-2020 | IPR001715 | Calponin homology domain |
| UnnamedSample_HQ_transcript/11688|m.4388 | UnnamedSample_HQ_transcript/11688 | Coverage 0.391 too low. | 6a2552511bee805e12422502f1d96a1c | 1027 | Pfam | PF13927 | Immunoglobulin domain | 470 | 553 | 1.2E-10 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/11688|m.4388 | UnnamedSample_HQ_transcript/11688 | Coverage 0.391 too low. | 6a2552511bee805e12422502f1d96a1c | 1027 | Pfam | PF07679 | Immunoglobulin I-set domain | 666 | 753 | 1.3E-16 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/11688|m.4388 | UnnamedSample_HQ_transcript/11688 | Coverage 0.391 too low. | 6a2552511bee805e12422502f1d96a1c | 1027 | Pfam | PF07679 | Immunoglobulin I-set domain | 571 | 662 | 1.7E-16 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/11688|m.4388 | UnnamedSample_HQ_transcript/11688 | Coverage 0.391 too low. | 6a2552511bee805e12422502f1d96a1c | 1027 | Pfam | PF13855 | Leucine rich repeat | 355 | 412 | 1.2E-10 | T | 22-09-2020 | IPR001611 | Leucine-rich repeat |
| UnnamedSample_HQ_transcript/11688|m.4388 | UnnamedSample_HQ_transcript/11688 | Coverage 0.391 too low. | 6a2552511bee805e12422502f1d96a1c | 1027 | Pfam | PF13855 | Leucine rich repeat | 233 | 275 | 3.3E-10 | T | 22-09-2020 | IPR001611 | Leucine-rich repeat |
| UnnamedSample_HQ_transcript/11688|m.4388 | UnnamedSample_HQ_transcript/11688 | Coverage 0.391 too low. | 6a2552511bee805e12422502f1d96a1c | 1027 | Pfam | PF13855 | Leucine rich repeat | 137 | 196 | 7.9E-13 | T | 22-09-2020 | IPR001611 | Leucine-rich repeat |
| UnnamedSample_HQ_transcript/11688|m.4388 | UnnamedSample_HQ_transcript/11688 | Coverage 0.391 too low. | 6a2552511bee805e12422502f1d96a1c | 1027 | Pfam | PF13855 | Leucine rich repeat | 279 | 339 | 2.8E-17 | T | 22-09-2020 | IPR001611 | Leucine-rich repeat |
| UnnamedSample_HQ_transcript/3266|m.1550 | UnnamedSample_HQ_transcript/3266 | Coverage 0.551 too low. | 6a2552511bee805e12422502f1d96a1c | 1027 | Pfam | PF13927 | Immunoglobulin domain | 470 | 553 | 1.2E-10 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/3266|m.1550 | UnnamedSample_HQ_transcript/3266 | Coverage 0.551 too low. | 6a2552511bee805e12422502f1d96a1c | 1027 | Pfam | PF07679 | Immunoglobulin I-set domain | 666 | 753 | 1.3E-16 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/3266|m.1550 | UnnamedSample_HQ_transcript/3266 | Coverage 0.551 too low. | 6a2552511bee805e12422502f1d96a1c | 1027 | Pfam | PF07679 | Immunoglobulin I-set domain | 571 | 662 | 1.7E-16 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/3266|m.1550 | UnnamedSample_HQ_transcript/3266 | Coverage 0.551 too low. | 6a2552511bee805e12422502f1d96a1c | 1027 | Pfam | PF13855 | Leucine rich repeat | 355 | 412 | 1.2E-10 | T | 22-09-2020 | IPR001611 | Leucine-rich repeat |
| UnnamedSample_HQ_transcript/3266|m.1550 | UnnamedSample_HQ_transcript/3266 | Coverage 0.551 too low. | 6a2552511bee805e12422502f1d96a1c | 1027 | Pfam | PF13855 | Leucine rich repeat | 233 | 275 | 3.3E-10 | T | 22-09-2020 | IPR001611 | Leucine-rich repeat |
| UnnamedSample_HQ_transcript/3266|m.1550 | UnnamedSample_HQ_transcript/3266 | Coverage 0.551 too low. | 6a2552511bee805e12422502f1d96a1c | 1027 | Pfam | PF13855 | Leucine rich repeat | 137 | 196 | 7.9E-13 | T | 22-09-2020 | IPR001611 | Leucine-rich repeat |
| UnnamedSample_HQ_transcript/3266|m.1550 | UnnamedSample_HQ_transcript/3266 | Coverage 0.551 too low. | 6a2552511bee805e12422502f1d96a1c | 1027 | Pfam | PF13855 | Leucine rich repeat | 279 | 339 | 2.8E-17 | T | 22-09-2020 | IPR001611 | Leucine-rich repeat |
| UnnamedSample_HQ_transcript/20468|m.6996 | UnnamedSample_HQ_transcript/20468 | Identity 0.610 too low. | 36d4d38329df0054fe50acd26dc21c76 | 900 | Pfam | PF09758 | Uncharacterised conserved protein | 49 | 196 | 4.2E-60 | T | 22-09-2020 | IPR019155 | CLEC16A/TT9, N-terminal |
| UnnamedSample_HQ_transcript/74968|m.18828 | UnnamedSample_HQ_transcript/74968 | Coverage 0.870 too low. | 6dc979308646a9c6f03ba341a2fe461d | 305 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 16 | 84 | 2.3E-14 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/74968|m.18828 | UnnamedSample_HQ_transcript/74968 | Coverage 0.870 too low. | 6dc979308646a9c6f03ba341a2fe461d | 305 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 107 | 164 | 1.2E-16 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/21129|m.7175 | UnnamedSample_HQ_transcript/21129 | Coverage 0.185 too low. | d3501f4a9b7e8385550fb8d914fbc001 | 964 | Pfam | PF15410 | Pleckstrin homology domain | 792 | 903 | 7.7E-34 | T | 22-09-2020 | IPR041681 | Pleckstrin homology domain 9 |
| UnnamedSample_HQ_transcript/21129|m.7175 | UnnamedSample_HQ_transcript/21129 | Coverage 0.185 too low. | d3501f4a9b7e8385550fb8d914fbc001 | 964 | Pfam | PF17820 | PDZ domain | 32 | 87 | 2.4E-8 | T | 22-09-2020 | IPR041489 | PDZ domain 6 |
| UnnamedSample_HQ_transcript/21129|m.7175 | UnnamedSample_HQ_transcript/21129 | Coverage 0.185 too low. | d3501f4a9b7e8385550fb8d914fbc001 | 964 | Pfam | PF01369 | Sec7 domain | 578 | 730 | 6.9E-44 | T | 22-09-2020 | IPR000904 | Sec7 domain |
| UnnamedSample_HQ_transcript/39150|m.11677 | UnnamedSample_HQ_transcript/39150 | Unmapped. | 6aa3b27dd20cc1f0809a8966782e89c5 | 419 | Pfam | PF02020 | eIF4-gamma/eIF5/eIF2-epsilon | 338 | 414 | 1.4E-20 | T | 22-09-2020 | IPR003307 | W2 domain |
| UnnamedSample_HQ_transcript/34528|m.10615 | UnnamedSample_HQ_transcript/34528 | Coverage 0.124 too low. | 50022aedb696e3ca1af10520999e007a | 333 | Pfam | PF00170 | bZIP transcription factor | 242 | 304 | 1.5E-17 | T | 22-09-2020 | IPR004827 | Basic-leucine zipper domain |
| UnnamedSample_HQ_transcript/119101|m.24783 | UnnamedSample_HQ_transcript/119101 | Coverage 0.985 too low. | c256c51f9a486e7f0e14b15859454e9e | 152 | Pfam | PF02538 | Hydantoinase B/oxoprolinase | 1 | 116 | 4.5E-42 | T | 22-09-2020 | IPR003692 | Hydantoinase B/oxoprolinase |
| UnnamedSample_HQ_transcript/4075|m.1831 | UnnamedSample_HQ_transcript/4075 | Identity 0.931 too low. | 21468c0aec2c6970a2f29f3341201743 | 1527 | Pfam | PF02172 | KIX domain | 727 | 756 | 1.0E-5 | T | 22-09-2020 | IPR003101 | Coactivator CBP, KIX domain |
| UnnamedSample_HQ_transcript/4075|m.1831 | UnnamedSample_HQ_transcript/4075 | Identity 0.931 too low. | 21468c0aec2c6970a2f29f3341201743 | 1527 | Pfam | PF02172 | KIX domain | 792 | 837 | 2.0E-13 | T | 22-09-2020 | IPR003101 | Coactivator CBP, KIX domain |
| UnnamedSample_HQ_transcript/4075|m.1831 | UnnamedSample_HQ_transcript/4075 | Identity 0.931 too low. | 21468c0aec2c6970a2f29f3341201743 | 1527 | Pfam | PF02135 | TAZ zinc finger | 371 | 448 | 5.0E-20 | T | 22-09-2020 | IPR000197 | Zinc finger, TAZ-type |
| UnnamedSample_HQ_transcript/4075|m.1831 | UnnamedSample_HQ_transcript/4075 | Identity 0.931 too low. | 21468c0aec2c6970a2f29f3341201743 | 1527 | Pfam | PF00439 | Bromodomain | 1279 | 1361 | 4.4E-18 | T | 22-09-2020 | IPR001487 | Bromodomain |
| UnnamedSample_HQ_transcript/4075|m.1831 | UnnamedSample_HQ_transcript/4075 | Identity 0.931 too low. | 21468c0aec2c6970a2f29f3341201743 | 1527 | Pfam | PF06001 | Domain of Unknown Function (DUF902) | 1373 | 1412 | 3.3E-23 | T | 22-09-2020 | IPR010303 | CREB-binding protein/p300, atypical RING domain |
| UnnamedSample_HQ_transcript/106093|m.23346 | UnnamedSample_HQ_transcript/106093 | Coverage 0.925 too low. | 50e27a49165cd5ae87137460b22b1635 | 162 | Pfam | PF12248 | Farnesoic acid 0-methyl transferase | 48 | 142 | 8.9E-26 | T | 22-09-2020 | IPR022041 | Farnesoic acid O-methyl transferase |
| UnnamedSample_HQ_transcript/113282|m.24217 | UnnamedSample_HQ_transcript/113282 | Identity 0.912 too low. | 50e27a49165cd5ae87137460b22b1635 | 162 | Pfam | PF12248 | Farnesoic acid 0-methyl transferase | 48 | 142 | 8.9E-26 | T | 22-09-2020 | IPR022041 | Farnesoic acid O-methyl transferase |
| UnnamedSample_HQ_transcript/17126|m.6044 | UnnamedSample_HQ_transcript/17126 | Coverage 0.450 too low. | 50e27a49165cd5ae87137460b22b1635 | 162 | Pfam | PF12248 | Farnesoic acid 0-methyl transferase | 48 | 142 | 8.9E-26 | T | 22-09-2020 | IPR022041 | Farnesoic acid O-methyl transferase |
| UnnamedSample_HQ_transcript/118962|m.24773 | UnnamedSample_HQ_transcript/118962 | Identity 0.901 too low. | 50e27a49165cd5ae87137460b22b1635 | 162 | Pfam | PF12248 | Farnesoic acid 0-methyl transferase | 48 | 142 | 8.9E-26 | T | 22-09-2020 | IPR022041 | Farnesoic acid O-methyl transferase |
| UnnamedSample_HQ_transcript/61867|m.16423 | UnnamedSample_HQ_transcript/61867 | Coverage 0.917 too low. | 0fc06ea0cf35868f7f321ba0c295d368 | 597 | Pfam | PF07533 | BRK domain | 482 | 522 | 3.6E-14 | T | 22-09-2020 | IPR006576 | BRK domain |
| UnnamedSample_HQ_transcript/61867|m.16423 | UnnamedSample_HQ_transcript/61867 | Coverage 0.917 too low. | 0fc06ea0cf35868f7f321ba0c295d368 | 597 | Pfam | PF07529 | HSA | 339 | 409 | 5.2E-18 | T | 22-09-2020 | IPR014012 | Helicase/SANT-associated domain |
| UnnamedSample_HQ_transcript/61867|m.16423 | UnnamedSample_HQ_transcript/61867 | Coverage 0.917 too low. | 0fc06ea0cf35868f7f321ba0c295d368 | 597 | Pfam | PF08880 | QLQ | 87 | 121 | 4.3E-10 | T | 22-09-2020 | IPR014978 | Glutamine-Leucine-Glutamine, QLQ |
| UnnamedSample_HQ_transcript/109660|m.23792 | UnnamedSample_HQ_transcript/109660 | Coverage 0.988 too low. | d3bddf07fae79cdaf3c78c5a376e6e48 | 194 | Pfam | PF10417 | C-terminal domain of 1-Cys peroxiredoxin | 158 | 192 | 6.0E-15 | T | 22-09-2020 | IPR019479 | Peroxiredoxin, C-terminal |
| UnnamedSample_HQ_transcript/109660|m.23792 | UnnamedSample_HQ_transcript/109660 | Coverage 0.988 too low. | d3bddf07fae79cdaf3c78c5a376e6e48 | 194 | Pfam | PF00578 | AhpC/TSA family | 7 | 137 | 2.7E-37 | T | 22-09-2020 | IPR000866 | Alkyl hydroperoxide reductase subunit C/ Thiol specific antioxidant |
| UnnamedSample_HQ_transcript/90044|m.21262 | UnnamedSample_HQ_transcript/90044 | Coverage 0.917 too low. | c097ba4b1916da0ef70c845e5f3c39ae | 253 | Pfam | PF05225 | helix-turn-helix, Psq domain | 19 | 53 | 4.2E-7 | T | 22-09-2020 | IPR007889 | DNA binding HTH domain, Psq-type |
| UnnamedSample_HQ_transcript/104130|m.23120 | UnnamedSample_HQ_transcript/104130 | Coverage 0.886 too low. | c097ba4b1916da0ef70c845e5f3c39ae | 253 | Pfam | PF05225 | helix-turn-helix, Psq domain | 19 | 53 | 4.2E-7 | T | 22-09-2020 | IPR007889 | DNA binding HTH domain, Psq-type |
| UnnamedSample_HQ_transcript/16123|m.5747 | UnnamedSample_HQ_transcript/16123 | Unmapped. | fa93164b1d494d2564ee04deb1c70e99 | 323 | Pfam | PF00680 | Viral RNA-dependent RNA polymerase | 5 | 268 | 2.0E-7 | T | 22-09-2020 | IPR001205 | RNA-directed RNA polymerase, C-terminal domain |
| UnnamedSample_HQ_transcript/90898|m.21389 | UnnamedSample_HQ_transcript/90898 | Unmapped. | da29b1eaeca2532a9b22c08936e0ab4b | 423 | Pfam | PF00910 | RNA helicase | 41 | 149 | 8.2E-19 | T | 22-09-2020 | IPR000605 | Helicase, superfamily 3, single-stranded DNA/RNA virus |
| UnnamedSample_HQ_transcript/96252|m.22133 | UnnamedSample_HQ_transcript/96252 | Unmapped. | 583b9f4d16549ae07668b8d50dd9ae1f | 314 | Pfam | PF13604 | AAA domain | 68 | 227 | 6.4E-10 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/110548|m.23903 | UnnamedSample_HQ_transcript/110548 | Coverage 0.525 too low. | ceb502a9990d1a37cc41fd24d2f651d3 | 207 | Pfam | PF00107 | Zinc-binding dehydrogenase | 30 | 158 | 9.8E-18 | T | 22-09-2020 | IPR013149 | Alcohol dehydrogenase, C-terminal |
| UnnamedSample_HQ_transcript/115456|m.24441 | UnnamedSample_HQ_transcript/115456 | Coverage 0.598 too low. | ceb502a9990d1a37cc41fd24d2f651d3 | 207 | Pfam | PF00107 | Zinc-binding dehydrogenase | 30 | 158 | 9.8E-18 | T | 22-09-2020 | IPR013149 | Alcohol dehydrogenase, C-terminal |
| UnnamedSample_HQ_transcript/66109|m.17233 | UnnamedSample_HQ_transcript/66109 | Coverage 0.981 too low. | b53f5dce8f6b1aa4d74ace01ac05fb36 | 529 | Pfam | PF00271 | Helicase conserved C-terminal domain | 347 | 454 | 9.6E-30 | T | 22-09-2020 | IPR001650 | Helicase, C-terminal |
| UnnamedSample_HQ_transcript/66109|m.17233 | UnnamedSample_HQ_transcript/66109 | Coverage 0.981 too low. | b53f5dce8f6b1aa4d74ace01ac05fb36 | 529 | Pfam | PF00270 | DEAD/DEAH box helicase | 137 | 306 | 2.4E-48 | T | 22-09-2020 | IPR011545 | DEAD/DEAH box helicase domain |
| UnnamedSample_HQ_transcript/49927|m.14008 | UnnamedSample_HQ_transcript/49927 | Coverage 0.919 too low. | b53f5dce8f6b1aa4d74ace01ac05fb36 | 529 | Pfam | PF00271 | Helicase conserved C-terminal domain | 347 | 454 | 9.6E-30 | T | 22-09-2020 | IPR001650 | Helicase, C-terminal |
A
B
C
D
E
F
G
H
I
J
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
| 1. Protein accession (e.g. P51587) | |||||||||
| 2. Sequence MD5 digest (e.g. 14086411a2cdf1c4cba63020e1622579) | |||||||||
| 3. Sequence length (e.g. 3418) | |||||||||
| 4. Analysis (e.g. Pfam / PRINTS / Gene3D) | |||||||||
| 5. Signature accession (e.g. PF09103 / G3DSA:2.40.50.140) | |||||||||
| 6. Signature description (e.g. BRCA2 repeat profile) | |||||||||
| 7. Start location | |||||||||
| 8. Stop location | |||||||||
| 9. Score - is the e-value (or score) of the match reported by member database method (e.g. 3.1E-52) | |||||||||
| 10. Status - is the status of the match (T: true) | |||||||||
| 11. Date - is the date of the run | |||||||||
| 12. (InterPro annotations - accession (e.g. IPR002093) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
| 13. (InterPro annotations - description (e.g. BRCA2 repeat) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
